Doximity, Inc.
Every calculator, already run for DOCS
Open the full toolkit →You have the numbers on DOCS. Get the argument.
A written report on which of these readings actually decide the outcome for Doximity, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
21 analysts covering DOCSAnalyst Price Target Disagreement for Doximity, Inc.
Wall Street's bull case implies +54% from the current price; the bear case implies -41%. A 95% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for DOCS
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Doximity, Inc.
Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-com…
DOCS — frequently asked
Is DOCS a buy right now?
Wall Street's consensus rating on Doximity, Inc. is Hold across 21 analysts, with a mean price target of $29.67 (-3% vs. the current $30.58). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is DOCS overvalued?
DOCS trades at 36.0x trailing earnings, against a DCF fair value of $32 per share. The current price implies 6% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is DOCS's next earnings date?
Doximity, Inc. is next scheduled to report earnings around Nov 5, 2026. A full DOCS research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Doximity, Inc.?
Analysts covering Doximity, Inc. (DOCS) range from a bear-case target of $18.00 to a bull-case high of $47.00, with a mean consensus target of $29.67 across 18 analysts. The spread of $29.00 (95% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Doximity, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Doximity, Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full DOCS research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Doximity, Inc., in minutes. 3 free reports included with every account — no credit card required.